Multi-omics analysis of a pig-to-human decedent kidney xenotransplant猪到人类逝者肾脏异种移植的多组学分析NatureIF48.52025-11-130PRE
Mapping inter-and intra-tumor heterogeneity in Ductal Carcinoma in situ and invasive breast cancer using integrative multi-omic profilingCANCER RESEARCHIF16.62024-05-020PRE
Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancerBREAST CANCER RESEARCH AND TREATMENTIF32024-03-241OAAI
Gut microbiota analyses of Saudi populations for type 2 diabetes-related phenotypes reveals significant associationBMC MICROBIOLOGYIF4.22022-12-137OAAI
Distinct roles for the Charcot-Marie-Tooth disease-causing endosomal regulators Mtmr5 and Mtmr13 in axon radial sorting and Schwann cell myelinationHUMAN MOLECULAR GENETICSIF3.22021-10-277OA
An In Vitro Model of Charcot-Marie-Tooth Disease Type 4B2 Provides Insight Into the Roles of MTMR13 and MTMR2 in Schwann Cell MyelinationASN NEUROIF3.72018-11-126OAAI
The CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expressionHUMAN MOLECULAR GENETICSIF3.22013-01-0735OA
Sbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodelingMOLECULAR BIOLOGY OF THE CELLIF2.72012-07-1563OAAI
Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in micePROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12008-03-2571OAAI
Myotubularin phosphatases: policing 3-phosphoinositidesTRENDS IN CELL BIOLOGYIF18.12006-08-01222PREAI
The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth diseaseJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92005-09-01111OAAI
The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactionsJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92004-03-0189OAAI
Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1JOURNAL OF BIOLOGICAL CHEMISTRYIF3.92002-04-0189OAAI